C07J 7/008
Substituted in position 21
Official title: {substituted in position 21}
C07J7/008 (Substituted in position 21) appears on 205 US grants and 180 published applications in this corpus.
Search patents in C07J- Granted patents
- 205
- Published applications
- 180
- Assignees
- 98
- Inventors
- 361
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 3 | 0 |
| 1978 | 4 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 6 | 0 |
| 1983 | 7 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 8 | 0 |
| 1987 | 4 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 5 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 1 | 2 |
| 2004 | 2 | 1 |
| 2005 | 2 | 3 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 1 | 3 |
| 2011 | 1 | 2 |
| 2012 | 0 | 2 |
| 2013 | 4 | 11 |
| 2014 | 7 | 12 |
| 2015 | 4 | 9 |
| 2016 | 12 | 11 |
| 2017 | 4 | 13 |
| 2018 | 6 | 8 |
| 2019 | 14 | 11 |
| 2020 | 5 | 15 |
| 2021 | 7 | 17 |
| 2022 | 7 | 13 |
| 2023 | 8 | 11 |
| 2024 | 8 | 11 |
| 2025 | 6 | 10 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders24 Mar 2026US 12,583,884 B2Aelis Farma
- Compositions and methods for treating CNS disorders27 Jan 2026US 12,534,495 B2Sage Therapeutics, Inc.
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Dec 2025US 12,509,487 B2The Texas A&M University System
- Neuroactive steroids, compositions and uses thereof18 Nov 2025US 12,473,327 B2Sage Therapeutics, Inc.
- Modified glucocorticoids9 Sep 2025US 12,410,209 B2Board of Regents, The University of Texas System
- Modified glucocorticoids30 Jul 2026US 2026/0217754 A1Board of Regents, The University of Texas System
- Process For The Production Of 21-(Acetyloxy)-17-(Propionyloxy)-Pregn-4-Ene-3,20-Dione4 Jun 2026US 2026/0152524 A1Industriale Chimica S.R.L.
- Neuroactive steroids, compositions, and uses thereof30 Apr 2026US 2026/0116911 A1Sage Therapeutics, Inc.
- Neuroactive steroids, compositions, and uses thereof30 Apr 2026US 2026/0116912 A1Sage Therapeutics, Inc.
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Apr 2026US 2026/0116913 A1The Texas A&M University System
Most cited
By later US patents
- Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series74US 5,939,545 ACoCensys, Inc. · 1999
- Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series62US 6,277,838 B1CoCensys, Inc. · 2001
- 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof59US 9,512,165 B2Sage Therapeutics, Inc. · 2016
- Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series57US 6,143,736 ACoCensys, Inc. · 2000
- 19-NOR neuroactive steroids and methods of use thereof49US 9,365,611 B2Sage Therapeutics, Inc. · 2016